Effect of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovary.
Effect of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovary.
复制标题
DOI:
10.1016/0006-2952(85)90225-4
复制
发表时间:
1985-10
影响因子:
5.8
通讯作者:
H. Su;G. Mazzei;W. Vogler;J. Kuo
中科院分区:
文献类型:
--
作者:
H. Su;G. Mazzei;W. Vogler;J. Kuo
Antiestrogens (tamoxifen, clomiphene and nafoxidine) were found to inhibit phospholipid/ Ca2+-dependent protein kinase (PL/Ca-PK. or protein kinase C). whereas estrogens (estradiol and diethylstilbesterol) and the weakly estrogenic chlorotrianisene were inactive. Kinetic analysis indicated that the antiestrogens inhibited PL/Ca-PK competitively with respect to phosphatidylserine (Ki= 16–27,μM), but non-competitively with Ca2+(Ki= 14–30μM). Tamoxifen, hut not diethylstilbesterol, also inhibited the phospholipid/Ca2+-dependent phosphorylation of various endogenous proteins from the total, solubilized fraction of the rat brain and ovary. Myosin light chain kinase, a calmodulin/Ca2+-dependent class of protein kinase, was similarly inhibited by tamoxifen: the drug, however, was without effect on cyclic AMP-dependent and cyclic GMP-dependent protein kinases. It is suggested that PL/ Ca-PK, by virtue of the hydrophobic interactions required for the enzyme activation, may represent a potential site of action for the lipophilic antiestrogens, in addition to the commonly recognized intracellular estrogen receptors.